Jeremy VisserDec 21, 20231 minVIDEO: New AD guidelines published with updated treatments and recommendationsThe AAAAI/ACAAI JTF has published updated AD guidelines based on new available treatments and evidence-based recommendations.
Jeremy VisserDec 13, 20231 minVIDEO: Abrocitinib safe and efficacious in AD patients with or without allergic comorbiditiesAbrocitinib is efficacious and well tolerated in AD patients with or without allergic comorbidities.
Jeremy VisserNov 30, 20231 minVIDEO: Pruritus, pain are main drivers of AD impact and HRQoL, according to studyPain and pruritus are the main contributors to AD burden and poor health-related QoL.
Allan RyanNov 13, 20231 min72% of AD patients report poor mental health symptoms for one to 10 days in the previous monthA survey from the National Eczema Association in the U.S. has revealed that patients with AD tend to experience poor mental health symptoms.